Table 2.

Patient, disease, and treatment characteristics (N = 17).

Characteristic	Value
Sex, n (%)
Male	15 (88)
Female	2 (12)
Age at diagnosis, median (range), y	67.4 (44.2–79.9)
Tumor location, n
Upper thoracic	1
Mid thoracic	6
Distal thoracic or gastroesophageal junction	10
Tumor histology ,n
Adenocarcinoma	15
Squamous cell carcinoma	2
Tumor (T) and nodal (N) stage, n
T2N0	2
T2N1	3
T3N0	5
T3N1	3
T3N2 or N3	3
T4N0	1
Treatment
Definitive CRT, n	8
Preoperative CRT, n	9
Radiation dose, median (range) GyRBE	50.4 (50.4–64.8)
Chemotherapy regimen (patients), n (%)
Carboplatin and paclitaxel	13 (76)
Cisplatin and fluorouracil	2 (12)
Cisplatin and docetaxel	1 (6)
Xeloda and oxaliplatin	1 (6)

Abbreviations: CRT; chemoradiation therapy.